2008;63:581 90. 891. van DD, Spoor M, Hijman R, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007;297:701 8. Hillis et al 2011 ACCF/AHA CABG Guideline e721 892. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic oper- ations. Meta-analysis of thirty years of clinical trials. J Thorac Car- diovasc Surg. 1992;104:590 9. 893. Goodman JS, Schaffner W, Collins HA, et al. Infection after cardio- vascular surgery. Clinical study including examination of antimicrobial prophylaxis. N Engl J Med. 1968;278:117 23. 894. Fong IW, Baker CB, McKee DC. The value of prophylactic antibiotics in aorat-coronary bypass operations: a double-blind randomized trial. J Thorac Cardiovasc Surg. 1979;78:908 13. 895. Fekety FR Jr, Cluff LE, Sabiston DC Jr, et al. A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg. 1969;57: 757 63. 896. Austin TW, Coles JC, Burnett R, et al. Aortocoronary bypass pro- cedures and sternotomy infections: a study of antistaphylococcal pro- phylaxis. Can J Surg. 1980;23:483 5. 897. Kaiser AB, Petracek MR, Lea JW, et al. efficacy of cefazolin, cefa- mandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg. 1987;206:791 7. 898. Bolon MK, Morlote M, Weber SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004; 38:1357 63. 899. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123:326 32. 900. Maki DG, Bohn MJ, Stolz SM, et al. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. 